Innate production of interleukin-10 and tumor necrosis factor affects the risk of multiple sclerosis

Annals of Neurology

Volumn 48, Issue 4, 2000, Pages 641-646

  De Jong, Brigit A ^a   Schrijver, Hans M ^b   Huizinga, Tom W J ^a   Bollen, Eduard L E M ^a   Polman, Chris H ^b   Uitdehaag, Bernard M J ^b   Kersbergen, Marja C ^a   Sturk, Augueste ^a   Westendorp, Rudi G J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; LEUKOCYTE ANTIGEN; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; BLOOD CULTURE; CLINICAL ARTICLE; DEMYELINATING DISEASE; FEMALE; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; INFECTION RISK; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN FAMILY;

ADULT; DISEASE PROGRESSION; FEMALE; HUMAN; INTERLEUKIN-10; MALE; MIDDLE AGE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0033797692     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200010)48:4<641::AID-ANA11>3.0.CO;2-Z     Document Type: Article

References (25)

1. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis
2. Primary progressive multiple sclerosis
3. A comparison of the pathology of primary and secondary progressive multiple sclerosis
4. Progress in determining the causes and treatment of multiple sclerosis
5. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. The Multiple Sclerosis Genetics Group
6. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases
7. A full genome search in multiple sclerosis
8. Human leukocyte antigen studies in multiple sclerosis
9. Genetic predisposition to multiple sclerosis as revealed by immunoprinting
10. Interleukin 10 secretion in relation to human IL-10 locus haplotypes
11. Genetic influence on cytokine production and fatal meningococcal disease
12. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
13. Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis
14. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
15. Determination of tumour necrosis factor-alpha and interleukin-10 production in a whole blood stimulation system: Assessment of laboratory error and individual variation
16. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation
17. Pathogenesis of multiple sclerosis
18. Oligodendrocyte injury is an early event in lesions of multiple sclerosis
19. Age-adjusted recurrence risks for relatives of patients with multiple sclerosis
20. The adhesion molecule and cytokine profile of multiple sclerosis lesions
21. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation
22. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice
23. Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system
24. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination